We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 3,074

Further details of NHS health surcharge announced
  • Kingsley Napley
  • European Union, United Kingdom
  • August 21 2014

In our update on 17 January regarding the publication of the Department of Health's response to the 2013 public consultation on migrant access and


EMA opens consultation on guidelines for core SmPC for human plasma derived products
  • Hogan Lovells
  • European Union
  • October 7 2014

On 1 October 2014 the European Medicines Agency ("EMA") opened a consultation on revisions to its guideline on core summary of product


Submitting product information to the European Medicines Agency
  • Eversheds LLP
  • European Union
  • August 22 2014

From 1 July 2016, the European Medicines Agency ("EMA") will implement the International Organization for Standardization ("ISO") Identification of


The new proposals for patent law may increase clinical trials conduct
  • Eversheds LLP
  • European Union, United Kingdom
  • August 21 2014

The Legislative Reform (Patents) Order 2014 (the "Order") is scheduled to come into force on 1 October 2014 (this may change during Parliamentary


Sunshine in the EU
  • Eversheds LLP
  • European Union
  • August 22 2014

Pharmaceutical companies and medical device manufacturers operating internationally need to be aware of increasing transparency and disclosure


The changes to the law on medical devices in the EU
  • Eversheds LLP
  • European Union
  • August 22 2014

For medical devices ("MDs") the law at European Union level is contained in three separate EU directives. These laws are under review and two new


11th legal affairs forum in Brussels, Belgium on March 26-27, 2015
  • McGuireWoods LLP
  • Belgium, European Union
  • March 12 2015

On March 26-27, 2015, the European Generic Medicines Association (EGA) will host its 11th Legal Affairs Forum in Brussels, Belgium. The Forum will


Stem cell patentability: European update following opinion of Advocate-General in ISCC and the Australian position
  • Freehills Patent Attorneys
  • Australia, European Union
  • August 18 2014

The recent Opinion of the Advocate-General suggests that a clarification and moderation of the Court of Justice of the European Union's (CJEU


Pharmaceutical trade mark confusion
  • Taylor Wessing
  • European Union
  • October 6 2014

As with any industry sector, trade marks are important tools for life sciences businesses to establish an appealing brand for their products. However


An update on the proposed EU revisions to the regulation of medical devices
  • Fasken Martineau DuMoulin LLP
  • European Union
  • October 8 2014

The existing European legislation which established a regulatory regime for medical devices is over 20 years old. The current regulatory regime